همهاخبارمکان‌یابراهنمای خریدتصاویرویدیومقالات علمی
درباره برتیناتماس با ماهوش مصنوعی رایگانایمیل رایگانمترجم رایگانDNS رایگانهواشناسیکاوش برتیناپشتیبانیتبلیغ در برتینا
درباره سرچحریم خصوصیشرایط

برتینا (فناوری پیشرفته پارسیان) شرکت دانش‌بنیان حوزه هوش مصنوعی

مکان یاب
ثبت کسب‌وکار
✨

پاسخ هوش مصنوعی

در حال تفکر...
academic.oup.com/jid/article-abstract/200/1/79/1746330PDF

Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS‐related lymphoma

…, HJ Stellbrink, M Heiden, C Kollan… - The Journal of …, 2009 - academic.oup.com
۱۷۰ ارجاع2009

Background. AIDS‐related lymphoma contributes to significant morbidity and mortality among human immunodeficiency virus (HIV)–infected patients receiving highly active …

www.nature.com/articles/s42004-025-01518-xPDF

Photo-thermoresponsive polypyrrole-crosslinked single-chain nanoparticles for photothermal therapy

…, D Schöffmann, J Laufer, H Lucas, J Kollan… - Communications …, 2025 - nature.com
۱۴ ارجاع2025

Irradiating a chromophore allows cancer diagnostics by photoacoustic (PA) imaging, but also causes transformation of light into thermal energy and so enables therapy by photothermal …

link.springer.com/article/10.1007/s15010-022-01919-3PDF

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany

D Schmidt, C Kollan, B Bartmeyer, V Bremer… - Infection, 2023 - Springer
۴۷ ارجاع2023

Introduction Objectives of this study, as part of a nation-wide HIV pre-exposure prophylaxis (PrEP) evaluation project, were to determine the incidence of infections with HIV, chlamydia, …

www.eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.7.1800398PDF

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058

…, B Gunsenheimer-Bartmeyer, C Kollan… - …, 2019 - eurosurveillance.org
۶۰ ارجاع2019

Background Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy for men-who-have-sex-with-men (MSM). The high cost of PrEP has until recently been a …

academic.oup.com/jid/article-abstract/203/3/364/2192191PDF

Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy

A Zoufaly, M An der Heiden, C Kollan… - Journal of Infectious …, 2011 - academic.oup.com
۸۸ ارجاع2011

Background. A subgroup of human immunodeficiency virus type 1 (HIV-1)–infected patients with severe immunodeficiency show persistently low CD4+ cell counts despite sustained …

www.eurosurveillance.org/content/10.2807/esm.11.09.00645-en

HIV incidence increasing in MSM in Germany: factors influencing infection dynamics

U Marcus, L Voss, C Kollan, O Hamouda - Eurosurveillance, 2006 - eurosurveillance.org
۱۱۱ ارجاع2006

After an initial peak in the mid-1980s, HIV incidence in men who have sex with men (MSM) declined in most western industrialised countries and then levelled off during the 1990s. …

link.springer.com/article/10.1186/1471-2334-14-148PDF

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors

B Karo, W Haas, C Kollan… - BMC infectious …, 2014 - Springer
۶۵ ارجاع2014

Background Tuberculosis (TB) still presents a leading cause of morbidity and mortality among people living with HIV/AIDS (PLWHA), including those on antiretroviral therapy. In this …

link.springer.com/article/10.1186/s12889-024-19198-yPDF

Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany

D Schmidt, Y Duport, C Kollan, U Marcus, S Iannuzzi… - BMC Public Health, 2024 - Springer
۲۰ ارجاع2024

Background Pre-exposure prophylaxis (PrEP) with oral emtricitabine/tenofovir disoproxil (FTC/TDF) proved highly efficient in preventing HIV. Since 09/2019, FTC/TDF-PrEP is covered …

journals.plos.org/plosone/articlePDF

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort

…, J Werning, K Keeren, S Somogyi, C Kollan… - PloS one, 2010 - journals.plos.org
۸۵ ارجاع2010

Background The aim of this study is to analyse the prevalence of transmitted drug resistance, TDR, and the impact of TDR on treatment success in the German HIV-1 Seroconverter …

pubs.acs.org/aidcbc/article/10/9/3222/354692

Intranasal administration of bedaquiline-loaded fucosylated liposomes provides anti-tubercular activity while reducing the potential for systemic side effects

…, M Cohrs, PR Neumann, H Lucas, J Kollan… - ACS infectious …, 2024 - ACS Publications
۱۲ ارجاع2024

Liposomal formulations of antibiotics for inhalation offer the potential for the delivery of high drug doses, controlled drug release kinetics in the lung, and an excellent safety profile. In …

۱۲۳۴۵۶۷۸...۹۱۰
بعدی